(Q38378337)

28 October 2017

Ovarian carcinoma diagnosis: the clinical impact of 15 years of change (English)

1 reference

28 October 2017

1 reference

2

C Blake Gilks

1 reference

28 October 2017

Stefan Kommoss

1

1 reference

28 October 2017

Andreas du Bois

series ordinal

3

1 reference

28 October 2017

Friedrich Kommoss

series ordinal

4

1 reference

28 October 2017

language of work or name

English

0 references

publication date

15 September 2016

1 reference

British Journal of Cancer

28 October 2017

1 reference

28 October 2017

115

1 reference

28 October 2017

8

1 reference

28 October 2017

993-999

1 reference

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

28 October 2017

start time

15 September 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

Diverse tumorigenic pathways in ovarian serous carcinoma

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

New insights into ovarian cancer pathology.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

31 August 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5061905

1 October 2018

https://api.crossref.org/works/10.1038%2FBJC.2016.273

Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.273

Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.273

7 January 2021

Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.273

7 January 2021

Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.273

7 January 2021

Grading ovarian serous carcinoma using a two-tier system

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.273

7 January 2021

Classification and Staging of Malignant Tumours in the Female Pelvis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27632374

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/BJC.2016.273

1 reference

Dimensions Publication ID

28 October 2017

0 references

1 reference

28 October 2017

PubMed publication ID

27632374

1 reference